{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:37:48Z","timestamp":1773866268967,"version":"3.50.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1136\/ijgc-00009577-200601000-00044","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T14:47:40Z","timestamp":1717080460000},"page":"277-282","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Phase II study of the American Brachytherapy Society guidelines for the use of high\u2013dose rate brachytherapy in the treatment of cervical carcinoma: is 45\u201350.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high\u2013dose rate brachytherapy tolerable?"],"prefix":"10.1016","volume":"16","author":[{"given":"T.P.","family":"Shakespeare","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K. H.C.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.F.","family":"Back","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.D.","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0005","series-title":"Radiation oncology","first-page":"681","article-title":"The uterine cervix","author":"Eifel","year":"2003"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0010","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0360-3016(91)90007-Q","article-title":"Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies","volume":"20","author":"Lanciano","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0167-8140(02)00384-5","article-title":"The irradiation tolerance dose of the proximal vagina","volume":"67","author":"Au","year":"2003","journal-title":"Radiother Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1148\/83.2.344","article-title":"Remote afterloading with intracavitary applicators","volume":"83","author":"Henschke","year":"1964","journal-title":"Radiology"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0025","first-page":"349","article-title":"HDR intracavity brachy-therapy for carcinoma of the cervix\u2014the Madison system I: clinical and radiobiological considerations","volume":"24","author":"Stitt","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0030","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0360-3016(92)90696-F","article-title":"High-dose rate brachytherapy for carcinoma of the cervix: high tech or high risk","volume":"24","author":"Eifel","year":"1992","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0035","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0360-3016(99)00262-X","article-title":"High\u2013dose-rate versus low\u2013dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence\u2014the university of Wisconsin experience","volume":"45","author":"Petereit","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0040","doi-asserted-by":"crossref","first-page":"S339","DOI":"10.1016\/S0360-3016(03)01226-4","article-title":"High dose rate versus low-dose rate intracavity radiotherapy in the treatment of cervical carcinoma: a meta-analysis","volume":"57","author":"Lee","year":"2003","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0045","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1016\/j.ijrobp.2004.01.034","article-title":"Phase III randomized trial comparing LDR and HDR brachytherapy in treatment of cervical carcinoma","volume":"59","author":"Lertsanguansinchai","year":"2004","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0360-3016(00)00497-1","article-title":"The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix","volume":"48","author":"Nag","year":"2000","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0055","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1056\/NEJM199904153401502","article-title":"Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer","volume":"340","author":"Rose","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1093\/jjco\/hyg069","article-title":"The trail of the development of high-dose-rate brachytherapy for cervical cancer in Japan","volume":"33","author":"Inoue","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0065","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0360-3016(03)00288-8","article-title":"Combination external beam radiotherapy and high-dose-rate intracavity brachytherapy for uterine cervical cancer: analysis of dose and fractionation schedule","volume":"56","author":"Toita","year":"2003","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/01.coc.0000128723.00352.ad","article-title":"A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer","volume":"27","author":"Lim","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0075","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/0360-3016(95)00220-S","article-title":"Carcinoma of the uterine cervix I. Impact of prolongation of overall treatment time and timing of brachytherapy on outcome of radiation therapy","volume":"32","author":"Perez","year":"1995","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0080","doi-asserted-by":"crossref","first-page":"S340","DOI":"10.1016\/S0360-3016(03)01228-8","article-title":"Low-dose-rate versus high-dose-rate intracavity brachytherapy for carcinoma of the cervix: the University of Alabama at Birmingham experience","volume":"57","author":"Falkenberg","year":"2003","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0085","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/0360-3016(91)90316-V","article-title":"Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation","volume":"21","author":"Orton","year":"1991","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0090","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0360-3016(02)04525-X","article-title":"Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens","volume":"55","author":"Wong","year":"2003","journal-title":"Int J Radiat Oncol Bio Phys"},{"key":"10.1136\/ijgc-00009577-200601000-00044_bib0095","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0360-3016(96)00624-4","article-title":"High-dose-rate intracavitary brachytherapy (HDR-IC) in the treatment of cervical cancer: 5-year results and implication of increased low-grade rectal complication on initiation of an HDR-IC fractionation scheme","volume":"38","author":"Wang","year":"1997","journal-title":"Int J Radiat Oncol Bio Phys"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24151547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24151547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-00009577-200601000-00044","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:34:12Z","timestamp":1753101252000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24151547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":19,"aliases":["10.1111\/j.1525-1438.2006.00373.x"],"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S1048891X24151547"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200601000-00044","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phase II study of the American Brachytherapy Society guidelines for the use of high\u2013dose rate brachytherapy in the treatment of cervical carcinoma: is 45\u201350.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high\u2013dose rate brachytherapy tolerable?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-00009577-200601000-00044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2006 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}